Facing increased pressures due to COVID-19, sickle cell disease patients await new solutions
Sickle cell disease affects more than 100,000 individuals in the United States and especially those of African American descent. Sickle cell disease patients need regular blood transfusions and two years of the COVID-19 pandemic have made that even more difficult — but there is hope.









